KALA BIO, Inc.
KALA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479419
No open-market purchases or sales by KALA BIO, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.21M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding KALA BIO, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 118 | 107 | −11 |
| Shares | 36.9M | 32.3M | −4.61M (−12.5%) |
| Value | $248.9M | $171.3M | −$77.6M (−31.2%) |
New holders (14)
Institutions that held KALA BIO, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pictet Asset Management Ltd | 392,107 | $2.08M | 0.00% |
| ACT Capital Management, LLC | 190,000 | $1.01M | 0.52% |
| Maverick Capital LtdSuperinvestorMaverick Capital | 81,664 | $433.0K | 0.00% |
| Centiva Capital, LP | 58,317 | $309.0K | 0.02% |
| Oppenheimer & Co Inc | 30,700 | $163.0K | 0.00% |
| Walleye Trading LLC | 28,736 | $152.0K | 0.00% |
| Susquehanna Fundamental Investments, LLC | 28,418 | $151.0K | 0.00% |
| Mercer Global Advisors Inc | 20,370 | $108.0K | 0.00% |
| Invesco Ltd. | 19,042 | $101.0K | 0.00% |
| Group One Trading, L.P. | 16,364 | $87.0K | 0.00% |
| Tudor Investment Corp Et Al | 11,912 | $63.0K | 0.00% |
| Arizona State Retirement System | 10,876 | $58.0K | 0.00% |
| Quantbot Technologies LP | 5,659 | $29.0K | 0.00% |
| First Manhattan Co | 1,400 | $7.00K | 0.00% |
Sold out (25)
Institutions that held KALA BIO, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.